q-bio.BMNov 12, 2026

Confident and Wrong: Structure Confidence Is a Poor Selection Filter for Protein Function

Authors: Eric LoPrete, Pavle Jeremić

Organizations: Aether Biomachines

Abstract

Structure-guided protein design can generate plausible candidates, but structural confidence does not predict function. We trained a function-guided model on measured metal-binding affinity with protein sequence, ligand identity, and assay conditions, and used it to design rare earth element (REE) binding variants of lanmodulin, a lanthanide-binding protein with four EF-hand domains. We screened 297 designs from three strategies against terbium and dysprosium, adjacent lanthanides among the hardest REE pairs to separate. Selection on structural confidence inverted the outcome it was meant to improve. The Structure-Confidence-Selected panel carried the highest pTM, complex ipLDDT, and composite confidence scores, and expressed at 97%, yet only 16.7% of its designs bound terbium (95% CI 10.4 to 25.7), against 83.3% (74.6 to 89.5) for the function-guided panel, whose confidence scores were the lowest. The odds of binding differed 25-fold between the two panels (Fisher exact p=1×10−20p = 1 \times 10^{-20}). No structural-confidence metric separated binders from non-binders consistently across panels, whereas the function-trained model's predicted pKd gave the highest ROC AUC in every panel, 0.79 to 0.92, and ranked measured affinity among function-guided binders at Spearman ρ=0.98ρ= 0.98. On the design objective, Tb/Dy selectivity, the function-guided designs also exceeded the natural lanmodulin family, outranking a randomly drawn ortholog 84% of the time across 149 orthologs. Structural confidence is a plausibility signal, not a selection criterion for function; direct supervision on measured function is what ranks designs.

Figures & tables

Appendix figures & tables3 assets

Supplementary material from the paper’s appendix.

Appendix

Explore similar work

May 15, 2026

Ligand-Conditioned Discrete Diffusion for Protein Sequence-Structure Co-Design

Proteins perform their biological functions through three-dimensional structures encoded by amino acid sequences, and ligand-binding protein co-design requires models that generate sequence-structure compatible proteins under explicit ligand constraints. Although continuous diffusion and flow-based models support ligand-aware design in coordinate or latent spaces, existing discrete diffusion protein language models mainly operate over sequence or structure tokens without direct small-molecule conditioning. We introduce \textbf{ProtLiD2^2}, a Protein Ligand-conditioned Discrete Diffusion model for protein sequence-structure co-design. ProtLiD2^2 jointly generates amino-acid sequence and discrete structure tokens while incorporating ligand chemical and geometric information through geometry-aware cross-attention. Trained on over one million ligand-protein complexes, ProtLiD2^2 extends masked discrete diffusion to ligand-aware functional protein design. We further propose maximum confidence-margin guided ReMask decoding, an inference-time self-correction strategy that retains confident predictions and remasks uncertain tokens. ProtLiD2^2 improves global fold confidence over Complexa in whole-protein design, increasing TM-score from 0.672 to 0.802 and pLDDT from 64.55 to 73.00. In pocket co-design, ProtLiD2^2 reduces active-site BB-RMSD from 3.46/3.40Å for FAIR/PocketGen to 1.97Å, and improves ligand-aware pass rates over PocketGen from 14.86% to 59.73% and from 6.08% to 23.49% under stricter docking thresholds. These results support ligand-conditioned discrete diffusion as an effective token-space framework for functional protein co-design. Code will be available at https://github.com/auroua/ProtLiD.
Oct 9, 2026

Designing Protein Structures from Natural Language

A central challenge in de novo protein design is generating proteins with desired structural and functional properties. Existing design models typically require a dedicated input representation for each property, limiting the design objectives they support. We develop Prompteina, the first all-atom structure generation model that supports new and broader design objectives specified in natural language, analogous to text-to-image generation. To train Prompteina, we construct Prompteina-Data, a paired text--protein structure dataset of 1.8M structures and 50M+ captions describing global and residue-specific structural and functional properties. We adapt Proteina-Complexa, a pretrained structure generation model, through text-conditioned pretraining and finetuning that aligns residues with their corresponding text. Prompteina outperforms baselines on 15 of 18 structural properties and generates proteins that more closely match descriptions of their intended functions. In binder design, it leads baselines on at least 13 of 20 targets and improves interface confidence by 14% over the strongest baseline. With iterative in silico feedback, Prompteina's gain over non-iterative generation is 57% larger than the next-best baseline on the hardest targets. Finally, we experimentally validate Prompteina designs against GM2A, a target with no reported de novo binders. We identify nine binders, with the strongest at an apparent KDK_{\mathrm{D}} of 107 nM. These results establish natural language as an effective and powerful conditioning interface for protein structure generation.
Nov 2, 2026

ProteoCraft: Protein Design as Proposal-Verification Search

Protein-protein interactions underpin nearly all biological processes. Yet, designing proteins with desired interactions remains challenging due to the structural complexity governing molecular recognition. This study views protein design as a search optimization problem over a combinatorial sequence space under expensive structural evaluation. Toward this goal, we introduce a novel tree-based search framework, ProteoCraft, that employs approximate structural gradients from diffusion-based structure predictors as effective proposal policies to specify where the search should explore. Complete no-gradient inference of folding models separately assigns values to the resulting sequences, determining what is good. ProteoCraft allocates this verification budget through a coarse-to-fine paradigm: multi-site edits first explore distinct sequence basins, then verified promising states undergo strict single-site refinement. Across fourteen de novo binder-design settings spanning eight target proteins, five immune-relevant TCR-facing targets, and four localized CDR redesign tasks, ProteoCraft improves design quality and high-confidence yield. These improvements persist under independent AF2-IG and Rosetta-based interface evaluation. Prospective experimental validation further yielded an 82.9% binding hit rate for PD-L1 miniproteins, with a best measured KD of 0.879 nM, and confirmed binding of designed IFNAR2 VHH. Our code is available at https://github.com/smiles724/ProteoCraft_v1.